M&A in pharma
Explores the merits of mega-deal in contrast to a more measured portfolio growth strategy
WTO & Patents
The impact on the pharmaceutical industry
| Publication Date | May 2000 |
| ISBN | 1859784429 |
| Pages | 0 |
| Tables | n/a |
| Figures | n/a |
Print £150 $285 |
Add to Basket |
PDF £175 $330 Single user |
Add to Basket |
Comprehensively reviews patent protection and its role within the global pharmaceutical industry. Assesses the importance of the TRIPS framework as a step toward globalisation of legal requirements and reviews the role of the WTO. Jargon-free, this publication will guide you through the most fundamental aspects of the industry.
Content
Executive Summary
1. An Introduction To Patents
2. Current Regulatory Processes, Effective Patent Life and The Pharmaceutical Life Cycle
3, International Institutions and Intellectual Property Rights Protection
4. The Trips Agreement and its Implications for Pharmaceuticals
5: Key Issues in the Implementation of the Trips Agreement and the Future
6. Ensuring Compliance with the Trips Agreement: WIPO Assistance to Developing Countries
7. Areas of Dispute in the WTO-Trips Agreement
8. Patent Issues in the US
9. Recent Advances in Intellectual Property Rights Protection in Europe
10. Parallel Trade and Orphan Drugs
11. The Effects of Patent Expiry, Generic Entry and Competition In The Pharmaceutical Sector
12. Intellectual Property Rights Protection in Other OECD and Developing Countries
Appendix A. The Patent Co-Operation Treaty
Appendix B. Definitions and Terminology
Useful References
Executive Summary
1. An Introduction To Patents
2. Current Regulatory Processes, Effective Patent Life and The Pharmaceutical Life Cycle
3, International Institutions and Intellectual Property Rights Protection
4. The Trips Agreement and its Implications for Pharmaceuticals
5: Key Issues in the Implementation of the Trips Agreement and the Future
6. Ensuring Compliance with the Trips Agreement: WIPO Assistance to Developing Countries
7. Areas of Dispute in the WTO-Trips Agreement
8. Patent Issues in the US
9. Recent Advances in Intellectual Property Rights Protection in Europe
10. Parallel Trade and Orphan Drugs
11. The Effects of Patent Expiry, Generic Entry and Competition In The Pharmaceutical Sector
12. Intellectual Property Rights Protection in Other OECD and Developing Countries
Appendix A. The Patent Co-Operation Treaty
Appendix B. Definitions and Terminology
Useful References